Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC

Completed

Conditions studied: Gram Negative Organism

In brief

The isolate samples will be collected over a period of one year once IRB approval has been obtained. These isolates were collected as part of the patient's clinical care and once all clinical testing is complete, all isolates will be discarded. The honest broker of our area will collect the isolates and deidentify all information once all clinical testing is complete. The isolates will be obtained from the microbiology lab.

Key facts

Study ID

NCT00443885

Run by

University of Pittsburgh

People needed

500

Starts

2007-02-01

Expected to finish

2017-01-01

Last updated by the study team

2018-06-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Samples" for the purpose of this study are Gram negative bacteria in a Petri dish of growth media.

Where it is running

• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
• UPMC — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.